Heidelberg Pharma AG (ETR:HPHA) | WebDisclosure

Basculer en Français

9474	Companies
185433	Keywords
117775	Articles
99293	Press releases

Home
Companies
Heidelberg Pharma AG

BRIEF

published on 05/27/2025 at 08:12, 6 months 9 days ago

Heidelberg Pharma Begins Phase I Study for HDP-102 in Non-Hodgkin Lymphoma

Heidelberg Pharma ADC Technology HDP-102 Non-Hodgkin Lymphoma Phase I Study
PRESS RELEASE

published on 05/27/2025 at 08:07, 6 months 9 days ago

Heidelberg Pharma Announces First Patient Dosed in Phase I Study of Amanitin-based ADC Candidate HDP-102 for Non-Hodgkin Lymphoma
Heidelberg Pharma dosed first patient in Phase I study of Amanitin-based ADC HDP-102 for Non-Hodgkin Lymphoma. ATAC technology targeting CD37. Promising data presented at AACR 2024

Heidelberg Pharma ATAC Technology Amanitin-based ADC Non-Hodgkin Lymphoma Phase I Study
BRIEF

published on 05/15/2025 at 14:36, 6 months 20 days ago

Heidelberg Pharma annonce les résultats de son assemblée générale annuelle et la création d'un nouveau conseil de surveillance

Biotechnologie Conseil De Surveillance Heidelberg Pharma ADC Assemblée Générale Annuelle 2025
BRIEF

published on 05/15/2025 at 14:36, 6 months 20 days ago

Heidelberg Pharma Announces AGM Results and New Supervisory Board

Supervisory Board Biotech Heidelberg Pharma ADCs AGM 2025
PRESS RELEASE

published on 05/15/2025 at 14:31, 6 months 20 days ago

Heidelberg Pharma Reports on the Results of the Ordinary Annual General Meeting 2025 and New Supervisory Board
Heidelberg Pharma AG reports on the results of the Ordinary Annual General Meeting 2025 and the appointment of a new Supervisory Board. Key decisions made include new board members and Dr. Karl Benedikt Biesinger elected as Chairman

Annual General Meeting Supervisory Board Heidelberg Pharma AG ADCs Dr. Karl Benedikt Biesinger
BRIEF

published on 05/14/2025 at 18:45, 6 months 21 days ago

Heidelberg Pharma to Unveil Clinical Data on HDP-101 at EHA 2025

Clinical Trial Heidelberg Pharma HDP-101 Multiple Myeloma EHA 2025
BRIEF

published on 05/14/2025 at 18:45, 6 months 21 days ago

Heidelberg Pharma dévoilera les données cliniques du HDP-101 à l'EHA 2025

Essai Clinique Heidelberg Pharma HDP-101 Myélome Multiple EHA 2025
PRESS RELEASE

published on 05/14/2025 at 18:40, 6 months 21 days ago

Heidelberg Pharma to Present Promising New Clinical Data on its Lead ATAC Candidate HDP-101 at EHA 2025
Heidelberg Pharma to present new clinical data on lead ATAC candidate HDP-101 at EHA 2025. Promising results in Multiple Myeloma treatment. R&D webinar to follow

Clinical Data Heidelberg Pharma Multiple Myeloma ATAC Candidate EHA 2025
BRIEF

published on 04/24/2025 at 07:21, 7 months 11 days ago

Rapport financier du premier trimestre 2025 de Heidelberg Pharma AG

Essais Cliniques Heidelberg Pharma Perspectives 2025 État Financier Programmes ADC
BRIEF

published on 04/24/2025 at 07:21, 7 months 11 days ago

Heidelberg Pharma AG's First Quarter Financial Report for 2025

Financial Statement Clinical Trials Heidelberg Pharma 2025 Outlook ADC Programs

Accesswire

Published on 12/05/2025 at 02:35, 7 hours 59 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 8 hours 4 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 9 hours 34 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 11 hours 29 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 11 hours 34 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 10:15, 19 minutes ago

Wuxi’s Liangxi District: Where 3,000 Years of Jiangnan Culture Thrives
Published on 12/05/2025 at 09:40, 54 minutes ago

Chery Partners with 2025 Asian Youth Para Games, Taking Center Stage in Global Sports with Passion and Aspiration
Published on 12/05/2025 at 09:30, 1 hour 4 minutes ago

REPLOID Group AG: Exhibitor at the BIOGAS Convention & Trade Fair in Nuremberg, Germany
Published on 12/05/2025 at 09:05, 1 hour 29 minutes ago

Transforming Football: IBM and Bayer 04 Leverkusen Use AI for Superior Game Analysis
Published on 12/05/2025 at 09:00, 1 hour 33 minutes ago

Original-Research: DEMIRE AG (von NuWays AG): BUY

Les Echos

Published on 12/05/2025 at 08:45, 1 hour 49 minutes ago

Air Liquide va étendre et électrifier son unité de production d'oxygène à Shaanxi, soutenant ainsi l'engagement de la Chine à décarboner son industrie
Published on 12/05/2025 at 08:45, 1 hour 49 minutes ago

Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/05/2025 at 08:42, 1 hour 51 minutes ago

ENGIE - déclaration mensuelle du nombre total d'actions et de droits de vote composant le capital au 30 novembre 2025
Published on 12/04/2025 at 18:14, 16 hours 19 minutes ago

Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 16 hours 34 minutes ago

Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025

View all LES ECHOS COMFI WIRE